Kusumoto M - Search Results

1

9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells.

Sato N, Mizumoto K, Kusumoto M, Niiyama H, Maehara N, Ogawa T, Tanaka M. Sato N, et al. Among authors: kusumoto m. FEBS Lett. 1998 Dec 18;441(2):318-21. doi: 10.1016/s0014-5793(98)01571-3. FEBS Lett. 1998. PMID: 9883907 Free article.

2

Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.

Suehara N, Mizumoto K, Kusumoto M, Niiyama H, Ogawa T, Yamaguchi K, Yokohata K, Tanaka M. Suehara N, et al. Among authors: kusumoto m. Am J Gastroenterol. 1998 Oct;93(10):1967-71. doi: 10.1111/j.1572-0241.1998.00557.x. Am J Gastroenterol. 1998. PMID: 9772067

3

Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.

Niiyama H, Mizumoto K, Kusumoto M, Ogawa T, Suehara N, Shimura H, Tanaka M. Niiyama H, et al. Among authors: kusumoto m. Cancer. 1999 May 15;85(10):2138-43. doi: 10.1002/(sici)1097-0142(19990515)85:10<2138::aid-cncr7>3.0.co;2-8. Cancer. 1999. PMID: 10326691

4

Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin.

Zhang L, Mizumoto K, Sato N, Ogawa T, Kusumoto M, Niiyama H, Tanaka M. Zhang L, et al. Among authors: kusumoto m. Cancer Lett. 1999 Aug 3;142(2):129-37. doi: 10.1016/s0304-3835(99)00107-x. Cancer Lett. 1999. PMID: 10463768

5

Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.

Kusumoto M, Ogawa T, Mizumoto K, Ueno H, Niiyama H, Sato N, Nakamura M, Tanaka M. Kusumoto M, et al. Clin Cancer Res. 1999 Aug;5(8):2140-7. Clin Cancer Res. 1999. PMID: 10473098

6

Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations.

Mizumoto K, Sato N, Kusumoto M, Niiyama H, Maehara N, Nishio S, Li Z, Ogawa T, Tanaka M. Mizumoto K, et al. Among authors: kusumoto m. Cancer Lett. 2000 Feb 28;149(1-2):85-94. doi: 10.1016/s0304-3835(99)00345-6. Cancer Lett. 2000. PMID: 10737712

7

Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential.

Sato N, Mizumoto K, Beppu K, Maehara N, Kusumoto M, Nabae T, Morisaki T, Katano M, Tanaka M. Sato N, et al. Among authors: kusumoto m. Cancer Lett. 2000 Jul 31;155(2):153-61. doi: 10.1016/s0304-3835(00)00421-3. Cancer Lett. 2000. PMID: 10822130

8

Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide.

Sato N, Mizumoto K, Kusumoto M, Nishio S, Maehara N, Urashima T, Ogawa T, Tanaka M. Sato N, et al. Among authors: kusumoto m. Br J Cancer. 2000 Jun;82(11):1819-26. doi: 10.1054/bjoc.2000.1117. Br J Cancer. 2000. PMID: 10839297 Free PMC article.

9

GM-CSF gene therapy using adenoviral vector in hamster pancreatic cancer.

Ogawa T, Kusumoto M, Mizumoto K, Sato N, Nagai E, Ikubo A, Aoki Y, Tanaka M. Ogawa T, et al. Among authors: kusumoto m. J Hepatobiliary Pancreat Surg. 2000;7(3):306-11. doi: 10.1007/s005340070053. J Hepatobiliary Pancreat Surg. 2000. PMID: 10982631

10

Centrosome abnormalities in pancreatic ductal carcinoma.

Sato N, Mizumoto K, Nakamura M, Nakamura K, Kusumoto M, Niiyama H, Ogawa T, Tanaka M. Sato N, et al. Among authors: kusumoto m. Clin Cancer Res. 1999 May;5(5):963-70. Clin Cancer Res. 1999. PMID: 10353727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters